Hire of new CEO Johan Källstrand – read more here
Reccan Diagnostics successfully raises SEK 15M in a new share issue. New owners are Cardeon Futuering Finance AB, Tibia Konsult AB and Jan Hain. BG Svensson join as board member. Read more here
Sten K Johnson Foundation award "Development of a predictive and stratifying biomarker panel in pancreatic cancer tissue".
Winner of the Lund University and Sparbanken Skåne award for future innovation "New serum test for diagnosis and prediction of pancreatic cancer".
Sweden's Innovation Agency (Vinnova) - Grant for Innovative Startup.
Lund University and Sparbanken Skåne honorary award for future innovation "Prognostic biomarker panel in pancreatic cancer".
Sten K Johnson Foundation award "Histone 1.3 - a novel and unique biomarker for pancreatic cancer".
Innovationskontor Syd - Accelarator grant.
Adjunct professor Lars Grundemar joins the board.
Christer Fåhraeus joins the board after becoming co-owner.
LU Holding becomes co-owner and Christine Widstrand joins the board.
The company was founded.